Trials / Completed
CompletedNCT01842880
MicroRNAs as Biomarkers in Patients With Chagas Disease
Validation of MicroRNAs as Biomarkers for Determining Patients Prognosis With Chagas Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Hospital Sao Rafael · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to analyze the efficacy of MicroRNAs as biomarkers on the Chagas Disease prognosis. This analysis will be done through the correlation between the plasmatic levels of this molecule with functional and laboratory tests.
Detailed description
The patients included in the study must at first sign the written consent. They shall be accompanied in the specialized outpatient clinics for Chagas disease - Hospital São Rafael - Centro de Biotecnologia e Terapia Celular. They will be submitted to several tests, including: * Collection of Blood samples for biochemical analysis; * Electrocardiogram; * Holter Electrocardiogram; * Echocardiogram; * Treadmill Test; * X-Ray Imaging; * Magnetic Resonance Imaging; * Evaluation of the quality of life through the application of questionnaires (SF 36 and the Minnesota Living With Heart Failure Questionnaire).
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-06-01
- Completion
- 2013-12-01
- First posted
- 2013-04-30
- Last updated
- 2015-02-20
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01842880. Inclusion in this directory is not an endorsement.